The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.
The sport, which launched in Germany in 2017, bills itself as the fastest-growing one in the world, with events now spanning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback